These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7507693)

  • 1. Male fertility after VAPEC-B chemotherapy for Hodgkin's disease and non-Hodgkin's lymphoma.
    Radford JA; Clark S; Crowther D; Shalet SM
    Br J Cancer; 1994 Feb; 69(2):379-81. PubMed ID: 7507693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VAPEC-B chemotherapy in the treatment of aggressive non-Hodgkin's lymphoma: a retrospective analysis of 45 patients.
    Singer JM; Mijovic A; Pettingale KW; Nethersell A; Dobbs HJ; Samaratunga IR; Lakhani A; Mufti GJ
    Clin Oncol (R Coll Radiol); 1995; 7(6):366-70. PubMed ID: 8590697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spermatogenesis in Hodgkin's lymphoma patients: a retrospective study of semen quality before and after different chemotherapy regimens.
    Paoli D; Rizzo F; Fiore G; Pallotti F; Pulsoni A; Annechini G; Lombardo F; Lenzi A; Gandini L
    Hum Reprod; 2016 Feb; 31(2):263-72. PubMed ID: 26705149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weekly VAPEC-B chemotherapy for high grade non-Hodgkin's lymphoma: results of treatment in 184 patients.
    Radford JA; Whelan JS; Rohatiner AZ; Deakin D; Harris M; Stansfeld AG; Swindell R; Wilkinson PM; James RD; Lister TA
    Ann Oncol; 1994 Feb; 5(2):147-51. PubMed ID: 7514433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follow-up of sperm concentration and motility in patients with lymphoma.
    Tal R; Botchan A; Hauser R; Yogev L; Paz G; Yavetz H
    Hum Reprod; 2000 Sep; 15(9):1985-8. PubMed ID: 10967000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ChlVPP/EVA hybrid versus the weekly VAPEC-B regimen for previously untreated Hodgkin's disease.
    Radford JA; Rohatiner AZ; Ryder WD; Deakin DP; Barbui T; Lucie NP; Rossi A; Dunlop DJ; Cowan RA; Wilkinson PM; Gupta RK; James RD; Shamash J; Chang J; Crowther D; Lister TA
    J Clin Oncol; 2002 Jul; 20(13):2988-94. PubMed ID: 12089229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy-induced non-Hodgkin's lymphoma in a patient with Hodgkin's disease--a case report.
    Burney IA; Malik IA
    J Pak Med Assoc; 1996 Jan; 46(1):14-5. PubMed ID: 8830160
    [No Abstract]   [Full Text] [Related]  

  • 8. [Semen preservation and gonadal toxicity in the treatment of non Hodgkin lymphoma. Experience at the Gustave-Roussy Institute from 1980 to 1993].
    Naccache P; Decaudin D; Koscielny S; Bendahmane B; Auger J; Munck JN
    Bull Cancer; 1996 Apr; 83(4):307-14. PubMed ID: 8680082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonadal function after MACOP-B or VACOP-B with or without dose intensification and ABMT in young patients with aggressive non-Hodgkin's lymphoma.
    Müller U; Stahel RA
    Ann Oncol; 1993 May; 4(5):399-402. PubMed ID: 7688980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonadal function following chemotherapy for Hodgkin's disease: a comparative study of MVPP and a seven-drug hybrid regimen.
    Clark ST; Radford JA; Crowther D; Swindell R; Shalet SM
    J Clin Oncol; 1995 Jan; 13(1):134-9. PubMed ID: 7799013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A doxorubicin-based regimen used in the treatment of elderly patients with high-grade non-Hodgkin's lymphoma.
    Wylie JP; Cowan RA; Radford JA; Deakin DP; Harris M; Wilkinson PM
    Clin Oncol (R Coll Radiol); 2000; 12(3):153-7. PubMed ID: 10942331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group.
    Eichenauer DA; Plütschow A; Kreissl S; Sökler M; Hellmuth JC; Meissner J; Mathas S; Topp MS; Behringer K; Klapper W; Kuhnert G; Dietlein M; Kobe C; Fuchs M; Diehl V; Engert A; Borchmann P
    Lancet Oncol; 2017 Dec; 18(12):1680-1687. PubMed ID: 29133014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Male infertility caused by the chemotherapy of Hodgkin's disease: MOPP versus ABVD.
    Ragni G; Lombardi C; Santoro A; Bestetti O; Wyssling H
    Acta Eur Fertil; 1983; 14(3):221-2. PubMed ID: 6199937
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibin B is superior to FSH as a serum marker for spermatogenesis in men treated for Hodgkin's lymphoma with chemotherapy during childhood.
    van Beek RD; Smit M; van den Heuvel-Eibrink MM; de Jong FH; Hakvoort-Cammel FG; van den Bos C; van den Berg H; Weber RF; Pieters R; de Muinck Keizer-Schrama SM
    Hum Reprod; 2007 Dec; 22(12):3215-22. PubMed ID: 17981817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial.
    Engert A; Haverkamp H; Kobe C; Markova J; Renner C; Ho A; Zijlstra J; Král Z; Fuchs M; Hallek M; Kanz L; Döhner H; Dörken B; Engel N; Topp M; Klutmann S; Amthauer H; Bockisch A; Kluge R; Kratochwil C; Schober O; Greil R; Andreesen R; Kneba M; Pfreundschuh M; Stein H; Eich HT; Müller RP; Dietlein M; Borchmann P; Diehl V; ; ;
    Lancet; 2012 May; 379(9828):1791-9. PubMed ID: 22480758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of lymphoma treatments on spermatogenesis and sperm deoxyribonucleic acid: a multicenter prospective study from the CECOS network.
    Bujan L; Walschaerts M; Brugnon F; Daudin M; Berthaut I; Auger J; Saias J; Szerman E; Moinard N; Rives N; Hennebicq S
    Fertil Steril; 2014 Sep; 102(3):667-674.e3. PubMed ID: 25044088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective, non-randomised phase 1-2 trial of VACOP-B with filgrastim support for HIV-related non-Hodgkin's lymphoma.
    Sawka CA; Shepherd FA; Franssen E; Brandwein J; Dotten DA; Routy JP; Walker IR; St-Louis J; Taylor M; Arts K; Crump M; Foote M
    Biotechnol Annu Rev; 2005; 11():381-9. PubMed ID: 16216784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
    Sieber M; Bredenfeld H; Josting A; Reineke T; Rueffer U; Koch T; Naumann R; Boissevain F; Koch P; Worst P; Soekler M; Eich H; Müller-Hermelink HK; Franklin J; Paulus U; Wolf J; Engert A; Diehl V;
    J Clin Oncol; 2003 May; 21(9):1734-9. PubMed ID: 12721249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term reduction in sperm count after chemotherapy with and without radiation therapy for non-Hodgkin's lymphomas.
    Pryzant RM; Meistrich ML; Wilson G; Brown B; McLaughlin P
    J Clin Oncol; 1993 Feb; 11(2):239-47. PubMed ID: 8426200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma.
    Fisher RI; Gaynor ER; Dahlberg S; Oken MM; Grogan TM; Mize EM; Glick JH; Coltman CA; Miller TP
    N Engl J Med; 1993 Apr; 328(14):1002-6. PubMed ID: 7680764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.